Literature DB >> 30306059

Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using 18F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma.

Noriyuki Fujima1, Kenji Hirata2, Tohru Shiga2, Koichi Yasuda3,4, Rikiya Onimaru3, Kazuhiko Tsuchiya5, Satoshi Kano6, Takatsugu Mizumachi6, Akihiro Homma6, Kohsuke Kudo1, Hiroki Shirato3,4.   

Abstract

BACKGROUND: To investigate the utility of quantitative morphological and intratumoral characteristics obtained by 18F-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG-PET/CT) for the prediction of treatment outcome in patients with nasal or paranasal cavity squamous cell carcinoma (SCC).
METHODS: Twenty-four patients with nasal or paranasal cavity SCC who received curative non-surgical therapy (a combination of super-selective arterial cisplatin infusion and radiotherapy) were retrospectively analyzed. From pre-treatment FDG-PET data, a total of 13 parameters of quantitative morphological characteristics (tumor volume, surface area and sphericity), intratumoral characteristics (the maximum and mean standard uptake value, three intratumoral histogram and four textural parameters) and total lesion glycolysis (TLG) were respectively calculated. Information regarding the treatment outcome was determined from the histological diagnosis or clinical follow-up. Each of the 13 quantitative parameters as well as T- and N-stage was assessed for its relation to treatment outcome of local control or failure.
RESULTS: In univariate analysis, significant differences in surface area and sphericity between the local control and failure groups were observed. The receiver operating characteristic (ROC) curve analysis showed that sphericity had the highest accuracy of 0.88. In the multivariate analysis, sphericity was revealed as an independent predictor of the local control or failure.
CONCLUSIONS: The quantitative parameters of sphericity are useful to predict the treatment outcome in patients with nasal or paranasal SCC.

Entities:  

Keywords:  Head and neck neoplasms; carcinoma, squamous cell; positron-emission tomography

Year:  2018        PMID: 30306059      PMCID: PMC6177367          DOI: 10.21037/qims.2018.09.09

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  26 in total

1.  Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.

Authors:  Hung-Ming Wang; Nai-Ming Cheng; Li-Yu Lee; Yu-Hua Dean Fang; Joseph Tung-Chieh Chang; Din-Li Tsan; Shu-Hang Ng; Chun-Ta Liao; Lan-Yan Yang; Tzu-Chen Yen
Journal:  Int J Cancer       Date:  2015-09-01       Impact factor: 7.396

2.  FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.

Authors:  Yoshimasa Kitagawa; Kazuo Sano; Sadahiko Nishizawa; Mikiko Nakamura; Toshiyuki Ogasawara; Norihiro Sadato; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-26       Impact factor: 9.236

3.  Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.

Authors:  Nai-Ming Cheng; Yu-Hua Dean Fang; Li-yu Lee; Joseph Tung-Chieh Chang; Din-Li Tsan; Shu-Hang Ng; Hung-Ming Wang; Chun-Ta Liao; Lan-Yan Yang; Ching-Han Hsu; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-23       Impact factor: 9.236

4.  [Development of a computer-aided diagnosis system for the distinction between benign and malignant gastric lesions].

Authors:  Nobumichi Nagano; Takami Matsuo; Takashi Itoh; Kenichiro Tomonari; Junji Shiraishi
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2012

5.  MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma.

Authors:  M Dang; J T Lysack; T Wu; T W Matthews; S P Chandarana; N T Brockton; P Bose; G Bansal; H Cheng; J R Mitchell; J C Dort
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

6.  Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.

Authors:  Kai-Ping Chang; Ngan-Ming Tsang; Chun-Ta Liao; Cheng-Lung Hsu; Ming-Jui Chung; Chuan-Wei Lo; Sheng-Chieh Chan; Shu-Hang Ng; Hung-Ming Wang; Tzu-Chen Yen
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

7.  Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.

Authors:  Jun Sato; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Takuya Asaka; Masaaki Miyakoshi; Shozo Okamoto; Tohru Shiga; Masanobu Shindoh; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

8.  Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.

Authors:  Frank Hofheinz; Alexandr Lougovski; Klaus Zöphel; Maria Hentschel; Ingo G Steffen; Ivayla Apostolova; Florian Wedel; Ralph Buchert; Michael Baumann; Winfried Brenner; Jörg Kotzerke; Jörg van den Hoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-22       Impact factor: 9.236

Review 9.  HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies.

Authors:  Rüveyda Dok; Sandra Nuyts
Journal:  Cancers (Basel)       Date:  2016-03-29       Impact factor: 6.639

10.  Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Authors:  Sheng-Chieh Chan; Nai-Ming Cheng; Chia-Hsun Hsieh; Shu-Hang Ng; Chien-Yu Lin; Tzu-Chen Yen; Cheng-Lung Hsu; Hung-Ming Wan; Chun-Ta Liao; Kai-Ping Chang; Jiun-Jie Wang
Journal:  Oncotarget       Date:  2017-03-04
View more
  5 in total

1.  Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.

Authors:  Jorge E Jimenez; Dong Dai; Guofan Xu; Ruiyang Zhao; Tengfei Li; Tinsu Pan; Linghua Wang; Yingyan Lin; Zhangyang Wang; David Jaffray; John D Hazle; Homer A Macapinlac; Jia Wu; Yang Lu
Journal:  Clin Nucl Med       Date:  2022-03-01       Impact factor: 7.794

2.  Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational 18F-FDG PET/CT study.

Authors:  Siyao Du; Hongzan Sun; Si Gao; Jun Xin; Zaiming Lu
Journal:  Quant Imaging Med Surg       Date:  2019-03

3.  Association between bone marrow fluorodeoxyglucose uptake and recurrence after curative surgical resection in patients with T1-2N0M0 lung adenocarcinoma: a retrospective cohort study.

Authors:  Tian-Cheng Li; Li-Li Wang; Bo-Le Liu; Jun-Jie Hong; Ni-Na Xu; Kun Tang; Xiang-Wu Zheng
Journal:  Quant Imaging Med Surg       Date:  2020-12

4.  Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study.

Authors:  Noriyuki Fujima; Yukie Shimizu; Daisuke Yoshida; Satoshi Kano; Takatsugu Mizumachi; Akihiro Homma; Koichi Yasuda; Rikiya Onimaru; Osamu Sakai; Kohsuke Kudo; Hiroki Shirato
Journal:  Cancers (Basel)       Date:  2019-06-10       Impact factor: 6.639

5.  Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Takeshi Kodaira; Masami Nishio; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Nobuhiro Hanai
Journal:  Diagnostics (Basel)       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.